About Carl Zeiss Meditec AG
Ticker
info
AFX
Trading on
info
XETRA
ISIN
info
DE0005313704
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Dr. Markus Weber
Headquarters
info
Göschwitzer Straße 51-52, Jena, undefined, Germany, 07745
Employees
info
2,066
Website
info
zeiss.com/meditec-ag/de/investor-relat
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Metrics
BasicAdvanced
Market cap
info
€5.75B
P/E ratio
info
32.66
EPS
info
€2.01
Dividend Yield
info
0.00%
Beta
info
1.12
Forward P/E ratio
info
35.59
EBIDTA
info
€213M
Ex dividend date
info
2025-03-27
Price & volume
Market cap
info
€5.75B
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.00
Dividend yield
info
0.00%
Forward dividend per share
info
€0.00
Forward dividend yield
info
0.00%
Payout ratio
info
54.73%
Valuation
P/E ratio
info
32.66
Forward P/E
info
35.59
PEG ratio
info
1.7
Trailing P/E
info
32.66
Price to sales
info
2.76
Price to book
info
2.96
Earnings
EPS
info
€2.01
EPS estimate (current quarter)
info
€0.28
EPS estimate (next quarter)
info
€0.43
EBITDA
info
€213M
Revenues (TTM)
info
€2.08B
Revenues per share (TTM)
info
€23.55
Technicals
Beta
info
1.12
52-week High
info
€119.70
52-week Low
info
€44.28
50-day moving average
info
€57.59
200-day moving average
info
€59.01
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
7.48%
ROA (TTM)
info
7.03%
Profit margin
info
7.54%
Gross profit margin
info
€1.09B
Operating margin
info
5.71%
Growth
Quarterly earnings growth (YoY)
info
57.10%
Quarterly revenue growth (YoY)
info
3.30%
Share stats
Outstanding Shares
info
87.5M
Float
info
34.5M
Insiders %
info
59.14%
Institutions %
info
22.55%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
€0.44
€0.48
8.36%
Q1 • 24Beat
€0.43
€0.55
21.34%
Q2 • 24Beat
€1.01
€0.51
96.33%
Q3 • 24Beat
€0.36
€0.28
28.07%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€580M
€60.7M
10.48%
Q3 • 24
€491M
€15.7M
3.20%
Q4 • 24
15.38%
74.15%
69.45%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€3.39B
€1.34B
39.39%
Q3 • 24
€-2.06B
0.00%
Q4 • 24
NaN%
253.85%
0.00%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€190M
€-56.2M
€-148M
€37.7M
Q3 • 24
-
-
-
-
Q4 • 24
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Carl Zeiss Meditec AG share?
Collapse

Carl Zeiss Meditec AG shares are currently traded for undefined per share.

How many shares does Carl Zeiss Meditec AG have?
Collapse

Carl Zeiss Meditec AG currently has 87.5M shares.

Does Carl Zeiss Meditec AG pay dividends?
Collapse

No, Carl Zeiss Meditec AG doesn't pay dividends.

What is Carl Zeiss Meditec AG 52 week high?
Collapse

Carl Zeiss Meditec AG 52 week high is €119.70.

What is Carl Zeiss Meditec AG 52 week low?
Collapse

Carl Zeiss Meditec AG 52 week low is €44.28.

What is the 200-day moving average of Carl Zeiss Meditec AG?
Collapse

Carl Zeiss Meditec AG 200-day moving average is €59.01.

Who is Carl Zeiss Meditec AG CEO?
Collapse

The CEO of Carl Zeiss Meditec AG is Dr. Markus Weber.

How many employees Carl Zeiss Meditec AG has?
Collapse

Carl Zeiss Meditec AG has 2,066 employees.

What is the market cap of Carl Zeiss Meditec AG?
Collapse

The market cap of Carl Zeiss Meditec AG is €5.75B.

What is the P/E of Carl Zeiss Meditec AG?
Collapse

The current P/E of Carl Zeiss Meditec AG is 32.66.

What is the EPS of Carl Zeiss Meditec AG?
Collapse

The EPS of Carl Zeiss Meditec AG is €2.01.

What is the PEG Ratio of Carl Zeiss Meditec AG?
Collapse

The PEG Ratio of Carl Zeiss Meditec AG is 1.7.